Previously reported risk factors for the clinical progression of BPH include age, serum PSA, prostate volume, Qmax, PVR, IPSS, chronic inflammation of the prostate, metabolic syndrome, intravesical prostatic protrusion, prostate transition zone volume, and transition zone index [19–25]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.